In October, the U.S. government issued Axim Biotechnologies Inc a patent for a cannabis-based suppository to treat irritable bowel syndrome.
from Reuters: U.S. https://ift.tt/2FMjoib
//
Friday, 30 November 2018
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment